Self‐Reinforced Bimetallic Mito‐Jammer for Ca 2+ Overload‐Mediated Cascade Mitochondrial Damage for Cancer Cuproptosis Sensitization
Authors:
Open Access
- 11 February 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (15) , e2306031
Abstract
Overproduction of reactive oxygen species (ROS), metal ion accumulation, and tricarboxylic acid cycle collapse are crucial factors in mitochondria‐mediated cell death. However, the highly adaptive nature and damage‐repair capabilities of malignant tumors strongly limit the efficacy of treatments based on a single treatment mode. To address this challenge, a self‐reinforced bimetallic Mito‐Jammer is developed by incorporating doxorubicin (DOX) and calcium peroxide (CaO 2 ) into hyaluronic acid (HA) ‐modified metal‐organic frameworks (MOF). After cellular, Mito‐Jammer dissociates into CaO 2 and Cu 2+ in the tumor microenvironment. The exposed CaO 2 further yields hydrogen peroxide (H 2 O 2 ) and Ca 2+ in a weakly acidic environment to strengthen the Cu 2+ ‐based Fenton‐like reaction. Furthermore, the combination of chemodynamic therapy and Ca 2+ overload exacerbates ROS storms and mitochondrial damage, resulting in the downregulation of intracellular adenosine triphosphate (ATP) levels and blocking of Cu‐ATPase to sensitize cuproptosis. This multilevel interaction strategy also activates robust immunogenic cell death and suppresses tumor metastasis simultaneously. This study presents a multivariate model for revolutionizing mitochondria damage, relying on the continuous retention of bimetallic ions to boost cuproptosis/immunotherapy in cancer.Keywords
Funding Information
- National Natural Science Foundation of China (82171946)
- National Natural Science Foundation of China (81873901)
- National Natural Science Foundation of China (82272025)
- National Natural Science Foundation of China (82102053)
This publication has 62 references indexed in Scilit:
- DNAzyme‐Mediated Cascade Nanoreactor for Cuproptosis‐Promoted Pancreatic Cancer Synergistic TherapyAdvanced Healthcare Materials, 2023
- Synergistic Reinforcing of Immunogenic Cell Death and Transforming Tumor‐Associated Macrophages Via a Multifunctional Cascade Bioreactor for Optimizing Cancer ImmunotherapyAdvanced Materials, 2022
- Recent Advances in Calcium‐Based Anticancer Nanomaterials Exploiting Calcium Overload to Trigger Cell ApoptosisAdvanced Functional Materials, 2022
- An Enzyme‐Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis‐Based Synergistic Cancer TherapyAdvanced Materials, 2022
- A Hollow Amorphous Bimetal Organic Framework for Synergistic Cuproptosis/Ferroptosis/Apoptosis Anticancer Therapy via Disrupting Intracellular Redox Homeostasis and Copper/Iron MetabolismsAdvanced Functional Materials, 2022
- Precise Subcellular Organelle Targeting for Boosting Endogenous‐Stimuli‐Mediated Tumor TherapyAdvanced Materials, 2021
- Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic‐Synergized Multimodal TherapyAdvanced Materials, 2021
- Mito‐Bomb: Targeting Mitochondria for Cancer TherapyAdvanced Materials, 2021
- Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional MaterialsAdvanced Materials, 2018
- Increased hyaluronidase levels in breast tumor metastasesInternational Journal of Cancer, 1997